Arcutis Biotherapeutics, Inc. ARQT Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s accrued liabilities, current?
- Arcutis Biotherapeutics, Inc. (ARQT) reported accrued liabilities, current of $136.96M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s accrued liabilities, current changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s accrued liabilities, current increased by 108.3% year-over-year, from $65.76M to $136.96M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s accrued liabilities, current has grown at a 49.7% compound annual growth rate (CAGR), from $15.46M to $116.31M.